Normal bone mineral content in young adults with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

被引:47
作者
Christiansen, P
Molgaard, C
Müller, J
机构
[1] Rigshosp, Dept Growth & Reprod, Sect GR5064, DK-2100 Copenhagen, Denmark
[2] Danish Vet & Agr Univ, Dept Human Nutr, Frederiksberg, Denmark
[3] Danish Vet & Agr Univ, Ctr Adv Food Studies, Frederiksberg, Denmark
[4] Rigshosp, Juliane Marie Ctr, Paediat Nutr Unit, DK-2100 Copenhagen, Denmark
关键词
bone mineral content; young adults; height; body composition; congenital adrenal hyperplasia;
D O I
10.1159/000075588
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To assess bone mineral content (BMC) and body composition in adolescents and young adults with congenital adrenal hyperplasia. Methods: BMC, anteroposterior-projected bone area ( BA), bone mineral density, and fat mass percentage were determined by dual-energy X-ray absorptiometry in 18 patients aged 18 - 33 years ( 8 females and 10 males) with 21-hydroxylase deficiency using a Hologic QDR 1000/W densitometer. Results: BMC and bone mineral density for age were significantly reduced at - 1.2 standard deviation scores (SDS; range from - 2.8 to + 4.1) and - 1.1 SDS ( range from - 3.2 to + 2.6), respectively. The BA for height was significantly increased at + 1.7 SDS ( range from - 0.5 to + 4.8), and the BMC for BA was normal at 0.3 SDS ( range from - 2.0 to + 3.6). The median final height was significantly reduced at - 1.6 SDS ( range from - 5.6 to + 0.3), and the fat mass percentage was significantly increased at + 1.5 SDS ( range from - 1.0 to + 5.0). Conclusion: Our study population of young adults with 21-hydroxylase deficiency had a short stature and broad bones with a normal BMC and had an increased fat mass percentage. Copyright (C) 2004 S. Karger AG, Basel.
引用
收藏
页码:133 / 136
页数:4
相关论文
共 24 条
[1]   Glucocorticoid excess during adolescence leads to a major persistent deficit in bone mass and an increase in central body fat [J].
Abad, V ;
Chrousos, GP ;
Reynolds, JC ;
Nieman, LK ;
Hill, SC ;
Weinstein, RS ;
Leong, GM .
JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (10) :1879-1885
[2]  
Andersen E, 1982, Ugeskr Laeger, V144, P1760
[3]   BONE-MINERAL DENSITY AND BODY-COMPOSITION IN CONGENITAL ADRENAL-HYPERPLASIA [J].
CAMERON, FJ ;
KAYMAKCI, B ;
BYRT, EA ;
EBELING, PR ;
WARNE, GL ;
WARK, JD .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (07) :2238-2243
[4]  
CARTER DR, 1992, J BONE MINER RES, V7, P137
[5]   THE EFFECT OF PHARMACOLOGICAL DOSAGES OF GLUCOCORTICOIDS ON FREE-LIVING TOTAL-ENERGY EXPENDITURE IN MAN [J].
CHONG, PKK ;
JUNG, RT ;
SCRIMGEOUR, CM ;
RENNIE, MJ .
CLINICAL ENDOCRINOLOGY, 1994, 40 (05) :577-581
[6]   The effects of glucocorticoid replacement therapy on growth, bone mineral density, and bone turnover markers in children with congenital adrenal hyperplasia [J].
Girgis, R ;
Winter, JSD .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (12) :3926-3929
[7]   Bone turnover and bone mineral density in patients with congenital adrenal hyperplasia [J].
Guo, CY ;
Weetman, AP ;
Eastell, R .
CLINICAL ENDOCRINOLOGY, 1996, 45 (05) :535-541
[8]   Bone mineral density in prepubertal and in adolescent and young adult patients with the salt-wasting form of congenital adrenal hyperplasia [J].
Gussinye, M ;
Carrascosa, A ;
Potau, N ;
Enrubia, M ;
VicensCalvet, E ;
Ibanez, L ;
Yeste, D .
PEDIATRICS, 1997, 100 (04) :671-674
[9]   Bone mass and body composition of adult women with congenital virilizing 21-hydroxylase deficiency after glucocorticoid treatment since infancy [J].
Hagenfeldt, K ;
Ritzén, EM ;
Ringertz, H ;
Helleday, J ;
Carlström, K .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2000, 143 (05) :667-671
[10]   Bone mineral density in relation to glucocorticoid substitution therapy in adult patients with 21-hydroxylase deficiency [J].
Jaaskelainen, J ;
Voutilainen, R .
CLINICAL ENDOCRINOLOGY, 1996, 45 (06) :707-713